Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | CCNC | P24863 | 1/20 | 0.31 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24803034 | 0.99 | NUDT1 (0.36) | NUDT1ESR1ESR2SCN9ACCNC | |
| SCHEMBL24802311 | 0.93 | NUDT1 (0.38) | NUDT1ESR1ESR2SCN9A | |
| SCHEMBL24802322 | 0.92 | NUDT1 (0.38) | NUDT1ESR1ESR2SCN9A | |
| SCHEMBL24801487 | 0.91 | NUDT1 (0.37) | NUDT1ESR1ESR2SCN9A | |
| SCHEMBL24802752 | 0.90 | NUDT1 (0.36) | NUDT1ESR1ESR2SCN9A | |
| SCHEMBL24801549 | 0.88 | MEN1 (0.39) | — | |
| SCHEMBL24801452 | 0.86 | NUDT1 (0.37) | NUDT1ESR1ESR2SCN9A | |
| SCHEMBL24801466 | 0.86 | MEN1 (0.35) | ESR1ESR2 | |
| SCHEMBL23609990 | 0.85 | NUDT1 (0.36) | NUDT1ESR1ESR2SCN9A | |
| SCHEMBL23609829 | 0.85 | NUDT1 (0.42) | NUDT1ESR1ESR2SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411411-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | LT MATERIALS CO.,LTD. (KR) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411411-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | CRY1, ODC1, ORC3 | NUDT1 515/4885ESR1 99/4885ESR2 489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.